T-cell receptor therapies

• Business
• Healthcare
• Investment
• News
• Pharma & Biotech
• Science
• Sweden
• United Kingdom

AstraZeneca completes acquisition of Neogene Therapeutics, expanding its portfolio in immuno-oncology

(PRESS RELEASE) CAMBRIDGE, 16-Jan-2023 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British-Swedish multinational pharmaceutical and biotechnology company, has announced the…